Skip to main content
PMC home page
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2015 Jan 6;5:288. doi: 10.3389/fphar.2014.00288

Effects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft tolerance

Anne Schumacher 1,*, Ana C Zenclussen 1
PMCID: PMC4285018  PMID: 25610397

Abstract

The heme-degrading enzyme heme oxygenase-1 (HO-1) has cytoprotective, antioxidant, and anti-inflammatory properties. Moreover, HO-1 is reportedly involved in suppressing destructive immune responses associated with inflammation, autoimmune diseases, and allograft rejection. During pregnancy, maternal tolerance to foreign fetal antigens is a prerequisite for successful embryo implantation and fetal development. Here, HO-1 has been implicated in counteracting the overwhelming inflammatory immune responses towards fetal allo-antigens, thereby contributing to fetal acceptance. Accordingly, HO-1 ablation negatively impacts the critical steps of pregnancy such as fertilization, implantation, placentation, and fetal growth. In the present review, we summarize recent data on the immune modulatory capacity of HO-1 towards allo-antigens expressed by the semi-allogeneic fetus and organ allografts. In this regard, HO-1 has been shown to promote alloantigen tolerance by blocking dendritic cell maturation resulting in reduced T cell responses and increased numbers of regulatory T cells. Moreover, HO-1 is suggested to shift the uterine cytokine milieu towards a protective Th2 profile and protects fetal tissue from apoptosis by upregulating anti-apoptotic molecules. Thus, HO-1 is not only a pivotal regulator of the initial steps of pregnancy; but also, an important player in supporting the maternal immune system in tolerating the fetus.

Keywords: allo-antigens, allograft, heme oxygenase-1, immune tolerance, pregnancy

INTRODUCTION

Heme oxygenase-1 (HO-1) has been widely described as an enzyme with anti-inflammatory, antioxidant, and cytoprotective functions. Moreover, due to its ability to modulate immune responses HO-1 has become an interesting target in several clinical specialties including infectious diseases, immunology (autoimmune diseases), oncology, transplantation, and obstetrics (fetal tolerance). HO-1 catalyzes the degradation of heme into biliverdin, carbon monoxide (CO) and free iron, and there is evidence that HO-1 mediates its functions through these byproducts. In response to inflammatory stimuli and oxidative stress HO-1 is induced in most cell types (Chauveau et al., 2005) where its expression activates or suppresses cell-intrinsic pathways. Hence, HO-1 is considered as one of the key regulators in the immunological network. Here, we focus this review on the immune regulating properties of HO-1 towards allo-antigens presented by the semi-allogeneic fetus or organ allografts on a cell-specific basis.

Under normal circumstances, recognition of foreign antigens by allo-reactive T cells causes inflammatory processes that result in the destruction of foreign antigens. During pregnancy, it is known that some degree of inflammation is required to ensure successful implantation of the blastocyst into the maternal endometrium. However, pregnancy complications may develop if inflammation becomes too excessive and is not counterbalanced by specific tolerance against paternal antigens. An adequate regulation of inflammation is thus a prerequisite for normal fetal development, and we believe that HO-1 is crucially involved in this process. In normal pregnancies, two HO isoforms, HO-1 and HO-2, are present in human, rat and mouse placenta (Kreiser et al., 2003; McLaughlin et al., 2003; Watanabe et al., 2004). HO-1 and HO-2 are differentially expressed and localized in the human placenta (McLean et al., 2000; Yoshiki et al., 2000). Extensive work from our group revealed that HO-1 controls critical phases throughout pregnancy including ovulation, fertilization, placentation, and fetal growth (Zenclussen et al., 2011, 2012; Linzke et al., 2014). The role of HO-1 in pregnancy was also explored by other research groups (Ahmed et al., 2000; Denschlag et al., 2004; Zhao et al., 2008,2009). Absence of HO-1 expression and/or its activity is associated with pregnancy complications in humans (Zenclussen et al., 2003; Denschlag et al., 2004) and mice (Zenclussen et al., 2011). Pharmacologic or gene therapy-mediated HO-1 upregulation protects the fetus from rejection (Sollwedel et al., 2005; Zenclussen et al., 2006) revealing the therapeutic potential of HO-1 in the treatment of pregnancy disorders.

In contrary to the physiologic condition of pregnancy, where the maternal immune system is naturally challenged by fetal allo-antigens, allotransplantation can be seen as an artificial situation where the immune system of the recipient must tolerate the foreign antigens expressed by the graft against its nature to accept it. However, it can be assumed that similar mechanisms contribute to allo-tolerance in both conditions and the knowledge of basic mechanisms by which the fetus guarantees its own survival may help to improve allograft acceptance. In agreement with observations made for pregnancy, HO-1 augmentation before or after allotransplantation is associated with increased allograft survival (Soares et al., 1998; DeBruyne et al., 2000; Chen et al., 2010; Evans et al., 2012). Thus, modulating the HO-1 system may be a promising tool to prevent acute and chronic rejections of allotransplants.

EFFECTS OF HO-1 ON MONOCYTES AND MACROPHAGES

Numbers, subtypes, and functions of monocytes and macrophages change during normal pregnancy. Both immune cell populations favor blastocyst implantation and placentation by promoting trophoblast invasion, spiral artery remodeling, and angiogenesis [recently reviewed in (Faas et al., 2014)]. Through its metabolite CO, HO-1 provokes differentiation of progenitors into functional macrophages. Hence, ablation of HO-1 has been shown to prevent macrophage differentiation and expression of its markers (Wegiel et al., 2014). Accordingly, a lack of HO-1 or its byproducts may impair implantation and placentation by affecting macrophage generation and activity.

Interestingly, HO-1 may also alter the course of autoimmune diseases and infections in pregnancy via modulation of myeloid-derived immune cell populations including monocytes and macrophages. Multiple sclerosis (MS), a Th1-dominated autoimmune disease, significantly improves during the third trimester of pregnancy and this is thought to be due to pregnancy-specific alterations of immune responses. In a well-established mouse model for MS, the experimental autoimmune encephalomyelitis (EAE), the authors observed that animals having a myeloid-specific HO-1 deficiency showed persistent activation of antigen-presenting cells (APCs), enhanced Th17 infiltration, and increased myelin-specific T cell reactivity resulting in a higher disease activity (Tzima et al., 2009). Moreover, Chora et al. (2007) nicely demonstrated that HO-1 and CO reduced disease activity in EAE mice. Although highly speculative, it can be assumed that HO-1 induction in pregnancy is involved in the attenuation of MS symptoms during this time. However, at present there is no direct proof for this beneficial effect.

Bacterial infections occurring during pregnancy are often associated with spontaneous abortions or preterm births. Macrophages are directly activated by microbial products and are involved in the first line of defense against bacterial invasion and colonization. Lipopolysaccharide (LPS), a component of the outer membrane of gram-negative bacteria, has been shown to induce HO-1 upregulation in rodent macrophages (Immenschuh et al., 1999), followed by a decreased expression of several pro-inflammatory genes (Otterbein et al., 2000). Additionally, gram-negative bacteria, such as Helicobacter pylori, induce polarization of macrophages to a more regulatory phenotype, resulting in a dampening of anti-bacterial immune responses (Gobert et al., 2014). Moreover, cell specific HO-1 inhibition in rodent macrophages was associated with a reduced expression of IFN-β after infection with the gram-positive bacteria Listeria monocytogenes. Because Listeria infection depends on IFN-β production, HO-1-deficient animals showed enhanced bacterial clearance and survival, while control mice succumbed to infection (Tzima et al., 2009). On the other hand, Tachibana et al. (2011) showed that Listeria infections decrease HO-1 expression and induce placental cell death. This is in agreement with our observations that mice infected with Tritrichomonas foetus lost their concepti and displayed a lower HO-1 expression in the uterus (Woudwyk et al., 2012). These findings suggest that regulation of HO-1 levels by bacteria favor bacterial persistence and, thereby facilitate embryonic death.

In organ transplantation, the effect of HO-1 on macrophages or its expression by these cells is proposed to favor allograft tolerance. Pre-treatment of pancreatic allografts prior to transplantation with cobalt protoporphyrin (CoPP), a HO-1 inducer, markedly increased HO-1 expression in donor macrophages. This was associated with a significant decrease in inflammatory cytokines and an increase in anti-inflammatory cytokines to result in adequate graft function and survival (Becker et al., 2007). In agreement, pre-treatment of recipients or islet allografts with bilirubin, a reduction product of biliverdin, before transplantation improved graft survival in recipient mice. Moreover, donor treatment only upregulated HO-1 mRNA expression and reduced the number of macrophages that infiltrate islet grafts in recipient mice (Wang et al., 2006).

EFFECTS OF HO-1 ON GRANULOCYTES

The effect of HO-1 on granulocytes in pregnancy and in allotransplantation has not been well studied. However, studies performed in rodent models of inflammation showed that HO-1 and its metabolites CO and biliverdin are able to reduce leukocyte rolling, adhesion, and neutrophil infiltration as well as migration of eosinophils to inflammatory sites (Freitas et al., 2006; Xia et al., 2007; Lin et al., 2010; Chiang et al., 2013; Zhang et al., 2013). In a human study, it was reported that treatment of partially purified basophils with hemin, a HO substrate analog, significantly induced biliverdin production in these cells, indicating that they do express HO. Additionally, hemin and exogenous CO seem to impair basophil activation (Vannacci et al., 2003). Interestingly, one study showed that activated regulatory T cells (Treg) initiate HO-1 expression in neutrophils rendering them to a suppressive phenotype (Lewkowicz et al., 2013). As Treg are major players in the establishment and maintenance of allo-tolerance, HO-1 induction in neutrophils may represent one mechanism by which Treg regulate innate immune responses towards allo-antigens.

EFFECTS OF HO-1 ON MAST CELLS

Mast cells (MCs) are key regulators of allergic diseases. After activation, MCs release pre-formed and newly synthesized mediators to induce inflammatory immune responses. Several studies have suggested a protective role of HO-1 and its metabolites in allergic inflammation partially mediated through MCs. Induction of HO-1 expression in MCs suppressed their degranulation and production of inflammatory cytokines (Takamiya et al., 2002; Yasui et al., 2007; Pae et al., 2008; Matsushima et al., 2009). Furthermore, HO-1-expressing murine MCs restrained dendritic cell (DC) maturation in vitro followed by a decreased capacity of the DCs to provoke proliferation of spleen mononuclear cells (Ma et al., 2014).

Recently, we uncovered a critical role of MCs in pregnancy success. We found that uterine MCs (uMCs) display a unique phenotype and increase in number when a female becomes receptive (Woidacki et al., 2013). Additionally, we confirmed an increase in HO-1 levels at the same time (Zenclussen et al., 2014). Hence, it is conceivable that HO-1 is involved in uterine homing of MCs as well as in their local regulation. However, a direct impact of HO-1 on MC migration and functionality needs to be confirmed. After pregnancy occurs, uMCs rapidly expand and contribute to trophoblast survival, placentation, and fetal growth (Woidacki et al., 2013) – processes in which HO-1 plays major roles (Zenclussen et al., 2006, 2011, 2012). It is, however, to remark that an exaggerated augmentation of MC numbers or their activation can be associated with negative pregnancy outcomes [reviewed in (Woidacki et al., 2014)]. Further studies are needed to analyze whether there is a direct association between HO-1 and MCs in pregnancy.

The role of MCs in allograft rejection or tolerance is still not defined. There is evidence that inflammation resulting in allograft rejection is suppressed by a reciprocal relationship between MCs and Treg. While MCs contribute to Treg migration and function in the graft, Treg were shown to mitigate MC degranulation. However, in the case of allergy, intragraft or systemic MC degranulation may impair Treg homing and suppression and may result in a breakdown of allograft tolerance (de Vries et al., 2009). The interaction between MCs and Treg in allograft tolerance is further underscored by a study of Lu et al. (2006). The authors showed that activated Treg produce high levels of IL-9, thereby recruiting and activating MCs in tolerant allografts where MCs can mediate regional immune suppression (Lu et al., 2006). To what extent HO-1 can regulate MC function and thereby contribute towards MC-mediated allograft acceptance is not fully understood and requires further investigations.

EFFECTS OF HO-1 ON NATURAL KILLER CELLS

Natural killer (NK) cells are the cytotoxic lymphocytes of the innate immune system that mainly respond to virally infected cells and tumor cells. During pregnancy, a unique subtype of NK cells, the so-called uterine NK (uNK) cells, represent the major cell fraction in the uterus. uNK cells express a specific receptor repertoire that differs from that of peripheral NK cells. However, the origin of uNK cells is still not defined. They may be converted from peripheral NK cells that are recruited to the uterus or may expand via in situ proliferation (Inoue et al., 1996; Borzychowski et al., 2003; van den Heuvel et al., 2005). In contrast to their undefined origin, there is a general consensus that they have an indispensable role for appropriate spiral artery remodeling that guarantees sufficient fetal nutrition (Hatta et al., 2011). We recently showed that HO-1 expression is important for the presence of uNKs and their expansion during pregnancy. We found that HO-1-deficient implantation sites have low uNK cell numbers and a decreased expression of uNK-related angiogenic factors. This phenotype was associated with shallow spiral artery formation leading to intrauterine growth restriction (IUGR) and gestational hypertension. Interestingly, we were able to restore the phenotype by application of low dose of CO during early to mid-gestation. CO treatment provoked an in situ proliferation of uNK cells, normalizing their numbers and further modulating angiogenic parameters that finally favor vascular remodeling and the prevention of hypertension (Linzke et al., 2014). Our results are in agreement with a study by Zhao et al. (2011) who showed that a partial HO-1 deficiency led to insufficient spiral artery remodeling and alterations of uNK differentiation and maturation. The authors further revealed that maternal HO-1 levels, but not fetal HO-1 levels, are important for a successful formation of the fetomaternal interface. These findings suggest a major influence of HO-1 on uNK cells during normal pregnancy (Zhao et al., 2011). Besides its pregnancy-favoring effect on uNK cells, HO-1 may also regulate NK cell function in allotransplantations, supporting allograft acceptance. It is well accepted that NK cells can promote rejection of allogeneic hematopoietic stem cells (Cudkowicz and Rossi, 1972). Furthermore, NK cells may also initiate solid organ transplant rejection by activating detrimental adaptive immune responses. In this regard, NK cells have been shown to eliminate immature DCs while sparing mature DCs, a behavior that promotes increased T cell activation (Degli-Esposti and Smyth, 2005). Moreover, NK cells can directly interact with T cells and induce their differentiation into Th1 cells (Martin-Fontecha et al., 2004). By killing Treg, NK cells further drive T cell-dependent allograft rejection (Roy et al., 2008). Application of heme into rats preceding cardiac allotransplantation augmented HO-1 levels followed by a reduction of peripheral NK cell numbers and prolonged allograft survival (Shen et al., 2011). However, data confirming a protective effect of HO-1 on NK cell-mediated allograft rejection are still scarce and further studies are still needed to clarify this point.

EFFECTS OF HO-1 ON DENDRITIC CELLS

Dendritric cells can be seen as intermediates between the innate and adaptive immune systems and have a major impact on the fate of the semi-allogeneic fetus and the allograft. By presenting allo-antigens, mature DCs can induce the activation and clonal expansion of allo-reactive T cells, thereby fostering the rejection process. However, immature DCs, secreting mainly anti-inflammatory cytokines, have been reported to suppress allo-responses and may therefore play a rather favorable role in both pregnancy and transplantation.

In terms of an effect mediated by HO-1, DCs are one of the best-studied immune cell populations. Several studies indicate that HO-1 affects both phenotype and function of DCs. Spontaneous HO-1 expression could be confirmed in immature human and rat DCs, while maturation resulted in a drastic decline of HO-1. In line, induction of HO-1 by CoPP-inhibited LPS-induced DC maturation, secretion of pro-inflammatory cytokines, and induction of reactive oxygen species (ROS). Additionally, such HO-1-producing DCs retained their ability to produce IL-10 and had a lower T cell stimulatory capacity. Accordingly, inhibition of HO activity led to increased ROS levels, a mature phenotype, impaired phagocytic and endocytic functions, and increased T cell stimulatory capacity (Al-Huseini et al., 2014). These findings support the idea that HO-1 directs DCs towards a tolerogenic profile. Normal pregnancy is characterized by uterine DCs (uDCs) presenting an immature phenotype and mainly producing IL-10 (Kammerer et al., 2003; Blois et al., 2004). In contrast, abortions in mice are associated with an increased number of mature, IL-12-producing DCs (Blois et al., 2005). Our working group showed in collaboration with Dr. Tadokoro that, in vivo, DCs accumulate even before pregnancy during the estrous cycle, suggesting a role for these cells in embryo implantation (Zenclussen et al., 2013). Indeed, Plaks et al. (2008) revealed that a depletion of uDCs had detrimental effects on the decidualization process by interfering with the implantation of the embryos, which finally lead to their demise. Furthermore, HO-1 supports pregnancy success by retaining DCs in an immature state, thereby attenuating allo-reactive T cell responses and promoting the expansion of pregnancy-favoring Treg (Schumacher et al., 2012).

Similar to fetal rejection, failure of allograft acceptance is often caused by direct and indirect antigen-presenting pathways where DCs initiate anti-alloantigen-specific adaptive immune responses. In a murine model for transplant arteriosclerosis, adoptive transfer of HO-1-deficient DCs before allograft transplantation or inhibition of endogenous HO-1 in allograft recipients was associated with pronounced intragraft T cell infiltration and increased IgG deposition, resulting in elevated graft immunogenicity (Cheng et al., 2010). On the other hand, HO-1 induction in organ donors prior to organ transplantation may reduce activation of donor DCs and intra-allograft T cell infiltration while simultaneously promoting Treg development (Kotsch et al., 2007; Sun et al., 2011). These findings indicate that HO-1 expression has a major impact on DCs, an immune cell population with the ability to induce or suppress allo-responses.

EFFECTS OF HO-1 ON B CELLS

B cells are allocated to the adaptive arm of the immune system and are best known for their capability to secrete antibodies. However, B cells are also able to efficiently present antigens and modulate the function of T cells and DCs by producing cytokines (Porakishvili et al., 2001; Youinou et al., 2005). Hence, it can be assumed that B cells are involved in essential immune regulatory processes promoting either fetal acceptance or rejection. We reported that various B cell subsets differentially affect pregnancy outcomes (Muzzio et al., 2013). In this regard, human B-1a B cells, known to produce poly reactive natural antibodies were reported to play a role in pre-eclampsia (Vannacci et al., 2003). In mice, B-1a B cells direct naive T cells towards an inflammatory Th1 and Th17 phenotype, and are therefore involved in cellular immune responses associated with pregnancy complications (Muzzio et al., 2014). In contrast, B cells contribute to fetal tolerance as well. It has been shown that the production of a structural unique type of antibodies, the so-called asymmetric antibodies, favor pregnancy success (Margni et al., 1976). Furthermore, there is evidence that IL-10-producing B cells with regulatory properties support fetal survival (Jensen et al., 2013; Rolle et al., 2013). The role of B cells in pregnancy has been recently reviewed (Fettke et al., 2014).

In the field of transplantation, B cells account for acute and chronic rejections (recently reviewed by (Nouel et al., 2014)). By presenting allo-antigens to T cells and by producing donor-specific antibodies, B cells initiate allograft rejection (Noorchashm et al., 2006). Intra-allograft B cell infiltration has therefore been associated with poor graft survival (Hippen et al., 2005). On the contrary, regulatory B cells (Bregs) have a rather favorable influence on allograft survival. Two human studies showed that an increased frequency of Bregs was found in tolerant renal transplanted patients (Newell et al., 2010; Pallier et al., 2010).

An action of HO-1 on B cells during pregnancy and organ transplantation is widely unexplored. HO-1 is expressed in normal and malignant human B cells after induction of oxidative stress, whereby malignant B cells exhibit a greater HO-1 expression (Bancos et al., 2010). Kapturczak et al. (2004) performed an elegant study, which compared the immune phenotype of HO-1 deficient with wild-type mice. Although the lack of HO-1 was associated with splenomegaly, analysis of splenocytes revealed no differences in the proportion of B cells. However, the authors found lower numbers of B220+ B cells in lymph nodes and significantly elevated serum IgM levels in HO-1-deficient animals (Kapturczak et al., 2004). In agreement, addition of heme to primary B cell cultures skews plasma cell differentiation toward the IgM isotype, decreasing IgG levels in vitro (Watanabe-Matsui et al., 2011). From these data, it can be assumed that in the presence of HO-1, destructive allo-antibody responses are controlled. In addition, injection of a recombinant adeno-associated viral vector (serotype 1) encoding IL-10 (rAAV1-IL-10) in a rat model of aortic allograft transplantation resulted in a significant reduction of graft infiltration with macrophages and B and T cells. The authors found that the protective effects of IL-10 were mediated through HO-1. This implies that HO-1 may regulate B cell infiltration into tissues where allo-antigens provoke inflammatory responses (Chen et al., 2005). This is a very interesting theory that needs further exploration.

EFFECTS OF HO-1 ON T CELLS

T lymphocytes are key regulators of humoral- and cell-mediated immune responses. T helper cells expressing CD4 and CD8-expressing cytotoxic T cells are the two main T cell subpopulations. Furthermore, although oversimplified, T cells are usually subdivided into Th1, Th2, Th9, and Th17 cells according to their cytokine secretion pattern. By secreting cytokines, T cells define their local environment as either pro-inflammatory or anti-inflammatory. Normal pregnancy is characterized by a pro-inflammatory Th1 profile at early and late pregnancy stages that is critical for proper trophoblast invasion and later on for initiation of labor. At mid-gestation, mechanisms allowing the acceptance of fetal allo-antigens provoke a more Th2-dominated profile. Imbalances in these cytokine profiles are thus often associated with pregnancy complications (Hudic and Fatusic, 2009).

After organ transplantation allo-antigens trigger the activation and proliferation of T cell responses. Consequently, CD8+ T cells induce cell-mediated cytotoxicity, while CD4+ T cells promote B cell maturation and differentiation into allo-antibody-producing plasma cells. Additionally, T cells secrete soluble factors that activate and recruit immune cells to the site of the allograft and finally provoke its rejection.

Modulation of T cell responses is suggested to be one of the major mechanisms by which HO-1 contributes to fetal and allograft survival. During normal pregnancy, HO-1 expression may at least partially be responsible for the Th2 shift observed during mid-gestation. This is supported in our studies, which showed that adenoviral-mediated upregulation of HO-1 in abortion-prone animals increased the Th2/Th1 ratio and protected fetuses from rejection (Zenclussen et al., 2006). Accordingly, induction of HO-1 by CoPP in allotransplant recipients led to a reduction in the pro-inflammatory cytokine milieu (Ewing et al., 2007), leading us to propose a similar protective mechanism during allotransplantation.

Treg are central players in the regulation of fetal and allograft tolerances. While an augmentation of Treg at the fetomaternal interface and in the allograft is associated with pregnancy success and a good prognosis of graft acceptance, the lack of Treg often results in pregnancy complications and allograft rejection.

Several studies indicate that HO-1 and its byproducts affect the development and function of human and murine CD4+ and CD8+ Treg as well as the production of Treg-related suppressive molecules (Pae et al., 2003; Choi et al., 2005; El Andaloussi and Lesniak, 2007; Lee et al., 2007; Xia et al., 2007; Brandsma et al., 2008; Mougiakakos et al., 2011; Sun et al., 2011; Karimi et al., 2012). Andersen et al. (2009) propose that Treg expressing HO-1 are able to inhibit cytokine release, proliferation, and cytotoxicity of other immune cells. However, this is in contrast, to a study by Biburger et al. (2010) who reported that HO-1 expression by human Treg influences their proliferative behavior, but not their suppressive capacity. Moreover, Zelenay et al. (2007) provided evidence that in HO-1-deficient animals, Treg development, maintenance, and function are independent of HO activity. In these animals, the absence of HO-1 in APCs seemed to abolish the suppressive activity of Treg (George et al., 2008). After previously reporting that adoptive Treg transfer can rescue fetuses from immunological rejection (Schumacher et al., 2012), we investigated the influence of HO-1 on Treg-mediated fetal protection. We proved that inhibition of HO-1 abrogated the protective effects of the Treg transfer suggesting that HO-1 is involved in a Treg-mediated suppression during murine pregnancies (Schumacher et al., 2012). Altogether these findings suggest that HO-1 affects several important aspects in T cell biology, including T cell proliferation, cytokine secretion, and the induction of T cells with regulatory properties. Hence, modulation of T cell and in particular Treg responses through HO-1 represent a promising tool for the induction of fetal and allotransplant tolerance.

EFFECTS OF HO-1 ON PROCESSES ENSURING TROPHOBLAST SURVIVAL

Placental development is a well-defined process of trophoblast proliferation and apoptosis. Irregularities within this process result in abnormal placentation and may cause pre-eclampsia, where an increased apoptotic rate of trophoblast cells was documented (Allaire et al., 2000; Sharp et al., 2010). HO-1 seems to directly influence trophoblast survival. By using a rat trophoblastic stem cell line that is capable of differentiating into trophoblast giant cells, we showed that HO-1 inhibition diminished cell viability and ability to differentiate into giant cells (Zenclussen et al., 2011). Thus, HO-1 regulates both the survival and maturation of trophoblast cells. Moreover, we found that adenoviral-mediated HO-1 induction in mice led to increased levels of the anti-apoptotic molecule Bag-1 and reduced the number of apoptotic cells in placental tissue (Zenclussen et al., 2006). In line, we recently confirmed that in partially deficient HO-1 animals, LPS treatment significantly reduced Bag-1 levels in placental tissue. In the same study, we found that human trophoblasts from spontaneous abortion patients had lower basal levels of HO-1 when compared to trophoblasts from normal pregnant women. The low HO-1 levels in trophoblasts from spontaneous abortion patients were further associated with a diminished Bag-1 expression (Kahlo et al., 2013). In an in vivo setting, we proved that exposure of CO during the implantation window and early placentation also reduced the number of apoptotic cells in the murine placenta and increased Bag-1 expression, implicating that the protective function of HO-1 might be mediated through its byproduct CO (El-Mousleh et al., 2012). Our work is in agreement with work from Zhao et al. (2009) who revealed that placentas from breedings of partially deficient HO-1 mice remained comparatively smaller and displayed lower placental weights than those from wild-type breedings. Lower HO-1 expression in heterozygous placentas was associated with an increase in apoptosis. These findings suggest that HO-1 not only modulates immune responses to ensure survival of fetal tissue; but also, supports pregnancy success by directly influencing trophoblast survival.

CONCLUSION

There is accumulating evidence that HO-1 and its byproducts affect the development and function of a variety of immune cells during pregnancy and allotransplantation (Figure 1). Detrimental immune responses towards the foreign allo-antigens are modulated and/or suppressed allowing the survival of the fetus in the hostile uterine environment and the acceptance of the allograft by its recipient. However, HO-1 deficiency may result in fetal and allograft rejection (Figure 2). HO-1-based therapies may be promising strategies to circumvent both, fetal and allotransplant rejections. These approaches may include pharmacologic or gene therapy-mediated induction of HO-1 as well as the administration of CO. Treg known to be essential for fetal and allotransplant tolerance may hereby represent a major target of HO-1 modulation.

FIGURE 1.

FIGURE 1

Open in a new tab

Hypothetical scenario of HO-1-mediated effects on innate and adaptive immune cell populations supporting fetal and allotransplant tolerance.

FIGURE 2.

FIGURE 2

Open in a new tab

Consequences of HO-1-deficiency for pregnancy outcome and allograft acceptance.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank our colleague Franziska Fettke for critically reading the manuscript.

REFERENCES

  1. Ahmed A., Rahman M., Zhang X., Acevedo C. H., Nijjar S., Rushton I., et al. (2000). Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol. Med. 6 391–409. [PMC free article] [PubMed] [Google Scholar]
  2. Al-Huseini L. M., Aw Yeang H. X., Hamdam J. M., Sethu S., Alhumeed N., Wong W., et al. (2014). Heme oxygenase-1 regulates dendritic cell function through modulation of p38 MAPK-CREB/ATF1 signaling. J. Biol. Chem. 289 16442–16451 10.1074/jbc.M113.532069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allaire A. D., Ballenger K. A., Wells S. R., McMahon M. J., Lessey B. A. (2000). Placental apoptosis in preeclampsia. Obstet. Gynecol. 96 271–276 10.1016/S0029-7844(00)00895-4 [DOI] [PubMed] [Google Scholar]
  4. Andersen M. H., Sorensen R. B., Brimnes M. K., Svane I. M., Becker J. C., thor Straten P. (2009). Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients. J. Clin. Invest. 119 2245–2256 10.1172/JCI38739 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bancos S., Baglole C. J., Rahman I., Phipps R. P. (2010). Induction of heme oxygenase-1 in normal and malignant B lymphocytes by 15-deoxy-Delta(12,14)-prostaglandin J(2) requires Nrf2. Cell. Immunol. 262 18–27 10.1016/j.cellimm.2009.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Becker T., Zu Vilsendorf A. M., Terbish T., Klempnauer J., Jorns A. (2007). Induction of heme oxygenase-1 improves the survival of pancreas grafts by prevention of pancreatitis after transplantation. Transplantation 84 1644–1655 10.1097/01.tp.0000290233.81395.81 [DOI] [PubMed] [Google Scholar]
  7. Biburger M., Theiner G., Schadle M., Schuler G., Tiegs G. (2010). Pivotal advance: heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity. J. Leukoc. Biol. 87 193–202 10.1189/jlb.0508280 [DOI] [PubMed] [Google Scholar]
  8. Blois S., Tometten M., Kandil J., Hagen E., Klapp B. F., Margni R. A., et al. (2005). Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies. J. Immunol. 174 1820–1829 10.4049/jimmunol.174.4.1820 [DOI] [PubMed] [Google Scholar]
  9. Blois S. M., Alba Soto C. D., Tometten M., Klapp B. F., Margni R. A., Arck P. C. (2004). Lineage, maturity, and phenotype of uterine murine dendritic cells throughout gestation indicate a protective role in maintaining pregnancy. Biol. Reprod. 70 1018–1023 10.1095/biolreprod.103.022640 [DOI] [PubMed] [Google Scholar]
  10. Borzychowski A. M., Chantakru S., Minhas K., Paffaro V. A., Yamada A. T., He H., et al. (2003). Functional analysis of murine uterine natural killer cells genetically devoid of oestrogen receptors. Placenta 24 403–411 10.1053/plac.2002.0924 [DOI] [PubMed] [Google Scholar]
  11. Brandsma C. A., Hylkema M. N., van der Strate B. W., Slebos D. J., Luinge M. A., Geerlings M., et al. (2008). Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells? Respir. Res. 9 17 10.1186/1465-9921-9-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chauveau C., Remy S., Royer P. J., Hill M., Tanguy-Royer S., Hubert F. X., et al. (2005). Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106 1694–1702 10.1182/blood-2005-02-0494 [DOI] [PubMed] [Google Scholar]
  13. Chen S., Kapturczak M. H., Wasserfall C., Glushakova O. Y., Campbell-Thompson M., Deshane J. S., et al. (2005). Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc. Natl. Acad. Sci. U.S.A. 102 7251–7256 10.1073/pnas.0502407102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chen X., Zhang Z., Su C., Gu W., Li H., Zhou G. (2010). Protective effect of heme oxygenase-1 to pancreas islet xenograft. J. Surg. Res. 164 336–343 10.1016/j.jss.2009.08.016 [DOI] [PubMed] [Google Scholar]
  15. Cheng C., Noorderloos M., van Deel E. D., Tempel D., den Dekker W., Wagtmans K., et al. (2010). Dendritic cell function in transplantation arteriosclerosis is regulated by heme oxygenase 1. Circ. Res. 106 1656–1666 10.1161/CIRCRESAHA.110.216945 [DOI] [PubMed] [Google Scholar]
  16. Chiang N., Shinohara M., Dalli J., Mirakaj V., Kibi M., Choi A. M., et al. (2013). Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J. Immunol. 190 6378–6388 10.4049/jimmunol.1202969 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Choi B. M., Pae H. O., Jeong Y. R., Kim Y. M., Chung H. T. (2005). Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem. Biophys. Res. Commun. 327 1066–1071 10.1016/j.bbrc.2004.12.106 [DOI] [PubMed] [Google Scholar]
  18. Chora A. A., Fontoura P., Cunha A., Pais T. F., Cardoso S., Ho P. P., et al. (2007). Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J. Clin. Invest. 117 438–447 10.1172/JCI28844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Cudkowicz G., Rossi G. B. (1972). Hybrid resistance to parental DBA-2 grafts: independence from the H-2 locus. I. Studies with normal hematopoietic cells. J. Natl. Cancer Inst. 48 131–139. [PubMed] [Google Scholar]
  20. DeBruyne L. A., Magee J. C., Buelow R., Bromberg J. S. (2000). Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival. Transplantation 69 120–128 10.1097/00007890-200001150-00021 [DOI] [PubMed] [Google Scholar]
  21. Degli-Esposti M. A., Smyth M. J. (2005). Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5 112–124 10.1038/nri1549 [DOI] [PubMed] [Google Scholar]
  22. Denschlag D., Marculescu R., Unfried G., Hefler L. A., Exner M., Hashemi A., et al. (2004). The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol. Hum. Reprod. 10 211–214 10.1093/molehr/gah024 [DOI] [PubMed] [Google Scholar]
  23. de Vries V. C., Wasiuk A., Bennett K. A., Benson M. J., Elgueta R., Waldschmidt T. J., et al. (2009). Mast cell degranulation breaks peripheral tolerance. Am. J. Transplant. 9 2270–2280 10.1111/j.1600-6143.2009.02755.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. El Andaloussi A., Lesniak M. S. (2007). CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas. J. Neurooncol. 83 145–152 10.1007/s11060-006-9314-y [DOI] [PubMed] [Google Scholar]
  25. El-Mousleh T., Casalis P. A., Wollenberg I., Zenclussen M. L., Volk H. D., Langwisch S., et al. (2012). Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications. Med. Gas Res. 2 4 10.1186/2045-9912-2-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Evans J. M., Navarro S., Doki T., Stewart J. M., Mitsuhashi N., Kearns-Jonker M. (2012). Gene transfer of heme oxygenase-1 using an adeno-associated virus serotype 6 vector prolongs cardiac allograft survival. J. Transplant. 2012 740653 10.1155/2012/740653 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ewing P., Hildebrandt G. C., Planke S., Andreesen R., Holler E., Gerbitz A. (2007). Cobalt protoporphyrine IX-mediated heme oxygenase-I induction alters the inflammatory cytokine response, but not antigen presentation after experimental allogeneic bone marrow transplantation. Int. J. Mol. Med. 20 301–308. [PubMed] [Google Scholar]
  28. Faas M. M., Spaans F., De Vos P. (2014). Monocytes and macrophages in pregnancy and pre-eclampsia. Front. Immunol. 5:298 10.3389/fimmu.2014.00298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Fettke F., Schumacher A., Costa S. D., Zenclussen A. C. (2014). B cells: the old new players in reproductive immunology. Front. Immunol. 5:285 10.3389/fimmu.2014.00285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Freitas A., Alves-Filho J. C., Secco D. D., Neto A. F., Ferreira S. H., Barja-Fidalgo C., et al. (2006). Heme oxygenase/carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br. J. Pharmacol. 149 345–354 10.1038/sj.bjp.0706882 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. George J. F., Braun A., Brusko T. M., Joseph R., Bolisetty S., Wasserfall C. H., et al. (2008). Suppression by CD4+CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigen-presenting cells. Am. J. Pathol. 173 154–160 10.2353/ajpath.2008.070963 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Gobert A. P., Verriere T., Asim M., Barry D. P., Piazuelo M. B., de Sablet T., et al. (2014). Heme oxygenase-1 dysregulates macrophage polarization and the immune response to Helicobacter pylori. J. Immunol. 193 3013–3022 10.4049/jimmunol.1401075 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hatta K., Carter A. L., Chen Z., Leno-Duran E., Ruiz-Ruiz C., Olivares E. G., et al. (2011). Expression of the vasoactive proteins AT1, AT2, and ANP by pregnancy-induced mouse uterine natural killer cells. Reprod. Sci. 18 383–390 10.1177/1933719110385136 [DOI] [PubMed] [Google Scholar]
  34. Hippen B. E., DeMattos A., Cook W. J., Kew C. E., Gaston R. S. (2005). Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am. J. Transplant. 5 2248–2252 10.1111/j.1600-6143.2005.01009.x [DOI] [PubMed] [Google Scholar]
  35. Hudic I., Fatusic Z. (2009). Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion. J. Perinat. Med. 37 338–342 10.1515/JPM.2009.061 [DOI] [PubMed] [Google Scholar]
  36. Immenschuh S., Tan M., Ramadori G. (1999). Nitric oxide mediates the lipopolysaccharide dependent upregulation of the heme oxygenase-1 gene expression in cultured rat Kupffer cells. J. Hepatol. 30 61–69 10.1016/S0168-8278(99)080008-7 [DOI] [PubMed] [Google Scholar]
  37. Inoue T., Kanzaki H., Imai K., Narukawa S., Katsuragawa H., Watanabe H., et al. (1996). Progesterone stimulates the induction of human endometrial CD56+ lymphocytes in an in vitro culture system. J. Clin. Endocrinol. Metab. 81 1502–1507 10.1210/jcem.81.4.8636358 [DOI] [PubMed] [Google Scholar]
  38. Jensen F., Muzzio D., Soldati R., Fest S., Zenclussen A. C. (2013). Regulatory B10 cells restore pregnancy tolerance in a mouse model. Biol. Reprod. 89 90 10.1095/biolreprod.113.110791 [DOI] [PubMed] [Google Scholar]
  39. Kahlo K., Fill Malfertheiner S., Ignatov T., Jensen F., Costa S. D., Schumacher A., et al. (2013). HO-1 as modulator of the innate immune response in pregnancy. Am. J. Reprod. Immunol. 70 24–30 10.1111/aji.12115 [DOI] [PubMed] [Google Scholar]
  40. Kammerer U., Eggert A. O., Kapp M., McLellan A. D., Geijtenbeek T. B., Dietl J., et al. (2003). Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am. J. Pathol. 162 887–896 10.1016/S0002-9440(10)63884-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kapturczak M. H., Wasserfall C., Brusko T., Campbell-Thompson M., Ellis T. M., Atkinson M. A., et al. (2004). Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165 1045–1053 10.1016/S0002-9440(10)63365-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Karimi K., Kandiah N., Chau J., Bienenstock J., Forsythe P. (2012). A Lactobacillus rhamnosus strain induces a heme oxygenase dependent increase in Foxp3+ regulatory T cells. PLoS ONE 7:e47556 10.1371/journal.pone.0047556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kotsch K., Martins P. N., Klemz R., Janssen U., Gerstmayer B., Dernier A., et al. (2007). Heme oxygenase-1 ameliorates ischemia/reperfusion injury by targeting dendritic cell maturation and migration. Antioxid. Redox. Signal. 9 2049–2063 10.1089/ars.2007.1801 [DOI] [PubMed] [Google Scholar]
  44. Kreiser D., Kelly D. K., Seidman D. S., Stevenson D. K., Baum M., Dennery P. A. (2003). Gestational pattern of heme oxygenase expression in the rat. Pediatr. Res. 54 172–178 10.1203/01.PDR.0000072516.83498.07 [DOI] [PubMed] [Google Scholar]
  45. Lee S. S., Gao W., Mazzola S., Thomas M. N., Csizmadia E., Otterbein L. E., et al. (2007). Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. FASEB J. 21 3450–3457 10.1096/fj.07-8472com [DOI] [PubMed] [Google Scholar]
  46. Lewkowicz N., Klink M., Mycko M. P., Lewkowicz P. (2013). Neutrophil-CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance. Immunobiology 218 455–464 10.1016/j.imbio.2012.05.029 [DOI] [PubMed] [Google Scholar]
  47. Lin Y. T., Chen Y. H., Yang Y. H., Jao H. C., Abiko Y., Yokoyama K., et al. (2010). Heme oxygenase-1 suppresses the infiltration of neutrophils in rat liver during sepsis through inactivation of p38 MAPK. Shock 34 615–621 10.1097/SHK.0b013e3181e46ee0 [DOI] [PubMed] [Google Scholar]
  48. Linzke N., Schumacher A., Woidacki K., Croy B. A., Zenclussen A. C. (2014). Carbon monoxide promotes proliferation of uterine natural killer cells and remodeling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant mice. Hypertension 63 580–588 10.1161/HYPERTENSIONAHA.113.02403 [DOI] [PubMed] [Google Scholar]
  49. Lu L. F., Lind E. F., Gondek D. C., Bennett K. A., Gleeson M. W., Pino-Lagos K., et al. (2006). Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 997–1002 10.1038/nature05010 [DOI] [PubMed] [Google Scholar]
  50. Ma Y. Y., Yang M. Q., Wang C. F., Ding J., Li J. Y. (2014). Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro. Inflamm. Res. 63 527–537 10.1007/s00011-014-0722-8 [DOI] [PubMed] [Google Scholar]
  51. Margni R. A., Paz C. B., Cordal M. E. (1976). Immunochemical behavior of sheep non-precipitating antibodies isolated by immunoadsorption. Immunochemistry 13 209–214 10.1016/0019-2791(76)90217-2 [DOI] [PubMed] [Google Scholar]
  52. Martin-Fontecha A., Thomsen L. L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. (2004). Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5 1260–1265 10.1038/ni1138 [DOI] [PubMed] [Google Scholar]
  53. Matsushima M., Takagi K., Ogawa M., Hirose E., Ota Y., Abe F., et al. (2009). Heme oxygenase-1 mediates the anti-allergic actions of quercetin in rodent mast cells. Inflamm. Res. 58 705–715 10.1007/s00011-009-0039-1 [DOI] [PubMed] [Google Scholar]
  54. McLaughlin B. E., Lash G. E., Smith G. N., Marks G. S., Nakatsu K., Graham C. H., et al. (2003). Heme oxygenase expression in selected regions of term human placenta. Exp. Biol. Med. 228 564–567. [DOI] [PubMed] [Google Scholar]
  55. McLean M., Bowman M., Clifton V., Smith R., Grossman A. B. (2000). Expression of the heme oxygenase-carbon monoxide signalling system in human placenta. J. Clin. Endocrinol. Metab. 85 2345–2349 10.1210/jcem.85.6.6705 [DOI] [PubMed] [Google Scholar]
  56. Mougiakakos D., Jitschin R., Johansson C. C., Okita R., Kiessling R., Le Blanc K. (2011). The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117 4826–4835 10.1182/blood-2010-12-324038 [DOI] [PubMed] [Google Scholar]
  57. Muzzio D., Zenclussen A. C., Jensen F. (2013). The role of B cells in pregnancy: the good and the bad. Am. J. Reprod. Immunol. 69 408–412 10.1111/aji.12079 [DOI] [PubMed] [Google Scholar]
  58. Muzzio D. O., Soldati R., Rolle L., Zygmunt M., Zenclussen A. C., Jensen F. (2014). B-1a B cells regulate T cell differentiation associated with pregnancy disturbances. Front. Immunol. 5:6 10.3389/fimmu.2014.00006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Newell K. A., Asare A., Kirk A. D., Gisler T. D., Bourcier K., Suthanthiran M., et al. (2010). Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120 1836–1847 10.1172/JCI39933 [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Noorchashm H., Reed A. J., Rostami S. Y., Mozaffari R., Zekavat G., Koeberlein B., et al. (2006). B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J. Immunol. 177 7715–7722 10.4049/jimmunol.177.11.7715 [DOI] [PubMed] [Google Scholar]
  61. Nouel A., Simon Q., Jamin C., Pers J. O., Hillion S. (2014). Regulatory B cells: an exciting target for future therapeutics in transplantation. Front. Immunol. 5:11 10.3389/fimmu.2014.00011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Otterbein L. E., Bach F. H., Alam J., Soares M., Tao Lu H., Wysk M., et al. (2000). Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6 422–428 10.1038/74680 [DOI] [PubMed] [Google Scholar]
  63. Pae H. O., Lee Y. C., Chung H. T. (2008). Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat. Inflamm. Allergy Drug Discov. 2 159–165 10.2174/187221308786241929 [DOI] [PubMed] [Google Scholar]
  64. Pae H. O., Oh G. S., Choi B. M., Chae S. C., Chung H. T. (2003). Differential expressions of heme oxygenase-1 gene in CD25- and CD25+ subsets of human CD4+ T cells. Biochem. Biophys. Res. Commun. 306 701–705 10.1016/S0006-291X(03)01037-4 [DOI] [PubMed] [Google Scholar]
  65. Pallier A., Hillion S., Danger R., Giral M., Racape M., Degauque N., et al. (2010). Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int. 78 503–513 10.1038/ki.2010.162 [DOI] [PubMed] [Google Scholar]
  66. Plaks V., Birnberg T., Berkutzki T., Sela S., BenYashar A., Kalchenko V., et al. (2008). Uterine DCs are crucial for decidua formation during embryo implantation in mice. J. Clin. Invest. 118 3954–3965 10.1172/JCI36682 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Porakishvili N., Mageed R., Jamin C., Pers J. O., Kulikova N., Renaudineau Y., et al. (2001). Recent progress in the understanding of B-cell functions in autoimmunity. Scand. J. Immunol. 54 30–38 10.1046/j.1365-3083.2001.00950.x [DOI] [PubMed] [Google Scholar]
  68. Rolle L., Memarzadeh Tehran M., Morell-Garcia A., Raeva Y., Schumacher A., Hartig R., et al. (2013). Cutting edge: IL-10-producing regulatory B cells in early human pregnancy. Am. J. Reprod. Immunol. 70 448–453 10.1111/aji.12157 [DOI] [PubMed] [Google Scholar]
  69. Roy S., Barnes P. F., Garg A., Wu S., Cosman D., Vankayalapati R. (2008). NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J. Immunol. 180 1729–1736 10.4049/jimmunol.180.3.1729 [DOI] [PubMed] [Google Scholar]
  70. Schumacher A., Wafula P. O., Teles A., El-Mousleh T., Linzke N., Zenclussen M. L., et al. (2012). Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS ONE 7:e42301 10.1371/journal.pone.0042301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Sharp A. N., Heazell A. E., Crocker I. P., Mor G. (2010). Placental apoptosis in health and disease. Am. J. Reprod. Immunol. 64 159–169 10.1111/j.1600-0897.2010.00837.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Shen Z., Teng X., Qian X., He M., Hu Y., Ye W., et al. (2011). Immunoregulation effect by overexpression of heme oxygenase-1 on cardiac xenotransplantation. Transplant. Proc. 43 1994–1997 10.1016/j.transproceed.2011.03.037 [DOI] [PubMed] [Google Scholar]
  73. Soares M. P., Lin Y., Anrather J., Csizmadia E., Takigami K., Sato K., et al. (1998). Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat. Med. 4 1073–1077 10.1038/2063 [DOI] [PubMed] [Google Scholar]
  74. Sollwedel A., Bertoja A. Z., Zenclussen M. L., Gerlof K., Lisewski U., Wafula P., et al. (2005). Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface. J. Immunol. 175 4875–4885 10.4049/jimmunol.175.8.4875 [DOI] [PubMed] [Google Scholar]
  75. Sun L., Shi T., Qiao H., Jiang X., Jiang H., Krissansen G. W., et al. (2011). Hepatic overexpression of heme oxygenase-1 improves liver allograft survival by expanding T regulatory cells. J. Surg. Res. 166 e187–e194 10.1016/j.jss.2010.11.917 [DOI] [PubMed] [Google Scholar]
  76. Tachibana M., Hashino M., Nishida T., Shimizu T., Watarai M. (2011). Protective role of heme oxygenase-1 in Listeria monocytogenes-induced abortion. PLoS ONE 6:e25046 10.1371/journal.pone.0025046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Takamiya R., Murakami M., Kajimura M., Goda N., Makino N., Takamiya Y., et al. (2002). Stabilization of mast cells by heme oxygenase-1: an anti-inflammatory role. Am. J. Physiol. Heart Circ. Physiol. 283 H861–H870 10.1152/ajpheart.00740.2001 [DOI] [PubMed] [Google Scholar]
  78. Tzima S., Victoratos P., Kranidioti K., Alexiou M., Kollias G. (2009). Myeloid heme oxygenase-1 regulates innate immunity and autoimmunity by modulating IFN-beta production. J. Exp. Med. 206 1167–1179 10.1084/jem.20081582 [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. van den Heuvel M. J., Xie X., Tayade C., Peralta C., Fang Y., Leonard S., et al. (2005). A review of trafficking and activation of uterine natural killer cells. Am. J. Reprod. Immunol. 54 322–331 10.1111/j.1600-0897.2005.00336.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Vannacci A., Baronti R., Zagli G., Marzocca C., Pierpaoli S., Bani D., et al. (2003). Carbon monoxide modulates the response of human basophils to FcepsilonRI stimulation through the heme oxygenase pathway. Eur. J. Pharmacol. 465 289–297 10.1016/S0014-2999(03)01489-4 [DOI] [PubMed] [Google Scholar]
  81. Wang H., Lee S. S., Dell’Agnello C., Tchipashvili V., d’Avila J. C., Czismadia E., et al. (2006). Bilirubin can induce tolerance to islet allografts. Endocrinology 147 762–768 10.1210/en.2005-0632 [DOI] [PubMed] [Google Scholar]
  82. Watanabe S., Akagi R., Mori M., Tsuchiya T., Sassa S. (2004). Marked developmental changes in heme oxygenase-1 (HO-1) expression in the mouse placenta: correlation between HO-1 expression and placental development. Placenta 25 387–395 10.1016/j.placenta.2003.10.012 [DOI] [PubMed] [Google Scholar]
  83. Watanabe-Matsui M., Muto A., Matsui T., Itoh-Nakadai A., Nakajima O., Murayama K., et al. (2011). Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 117 5438–5448 10.1182/blood-2010-07-296483 [DOI] [PubMed] [Google Scholar]
  84. Wegiel B., Hedblom A., Li M., Gallo D., Csizmadia E., Harris C., et al. (2014). Heme oxygenase-1 derived carbon monoxide permits maturation of myeloid cells. Cell. Death Dis. 5 e1139. 10.1038/cddis.2014.97 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Woidacki K., Popovic M., Metz M., Schumacher A., Linzke N., Teles A., et al. (2013). Mast cells rescue implantation defects caused by c-kit deficiency. Cell. Death Dis. 4 e462. 10.1038/cddis.2012.214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Woidacki K., Zenclussen A. C., Siebenhaar F. (2014). Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome? Front. Immunol. 5:231 10.3389/fimmu.2014.00231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Woudwyk M. A., Monteavaro C. E., Jensen F., Soto P., Barbeito C. G., Zenclussen A. C. (2012). Study of the uterine local immune response in a murine model of embryonic death due to Tritrichomonas foetus. Am. J. Reprod. Immunol. 68 128–137 10.1111/j.1600-0897.2012.01159.x [DOI] [PubMed] [Google Scholar]
  88. Xia Z. W., Xu L. Q., Zhong W. W., Wei J. J., Li N. L., Shao J., et al. (2007). Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1. Am. J. Pathol. 171 1904–1914 10.2353/ajpath.2007.070096 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Yasui Y., Nakamura M., Onda T., Uehara T., Murata S., Matsui N., et al. (2007). Heme oxygenase-1 inhibits cytokine production by activated mast cells. Biochem. Biophys. Res. Commun. 354 485–490 10.1016/j.bbrc.2006.12.228 [DOI] [PubMed] [Google Scholar]
  90. Yoshiki N., Kubota T., Aso T. (2000). Expression and localization of heme oxygenase in human placental villi. Biochem. Biophys. Res. Commun. 276 1136–1142 10.1006/bbrc.2000.3551 [DOI] [PubMed] [Google Scholar]
  91. Youinou P., Jamin C., Pers J. O., Berthou C., Saraux A., Renaudineau Y. (2005). B lymphocytes are required for development and treatment of autoimmune diseases. Ann. N. Y. Acad. Sci. 1050 19–33 10.1196/annals.1313.003 [DOI] [PubMed] [Google Scholar]
  92. Zelenay S., Chora A., Soares M. P., Demengeot J. (2007). Heme oxygenase-1 is not required for mouse regulatory T cell development and function. Int. Immunol. 19 11–18 10.1093/intimm/dxl116 [DOI] [PubMed] [Google Scholar]
  93. Zenclussen A. C., Lim E., Knoeller S., Knackstedt M., Hertwig K., Hagen E., et al. (2003). Heme oxygenases in pregnancy II: HO-2 is downregulated in human pathologic pregnancies. Am. J. Reprod. Immunol. 50 66–76 10.1034/j.1600-0897.2003.00047.x [DOI] [PubMed] [Google Scholar]
  94. Zenclussen A. C., Olivieri D. N., Dustin M. L., Tadokoro C. E. (2013). In vivo multiphoton microscopy technique to reveal the physiology of the mouse uterus. Am. J. Reprod. Immunol. 69 281–289 10.1111/aji.12066 [DOI] [PubMed] [Google Scholar]
  95. Zenclussen M. L., Anegon I., Bertoja A. Z., Chauveau C., Vogt K., Gerlof K., et al. (2006). Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. J. Reprod. Immunol. 69 35–52 10.1016/j.jri.2005.10.001 [DOI] [PubMed] [Google Scholar]
  96. Zenclussen M. L., Casalis P. A., El-Mousleh T., Rebelo S., Langwisch S., Linzke N., et al. (2011). Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. J. Pathol. 225 293–304 10.1002/path.2946 [DOI] [PubMed] [Google Scholar]
  97. Zenclussen M. L., Casalis P. A., Jensen F., Woidacki K., Zenclussen A. C. (2014). Hormonal fluctuations during the estrous cycle modulate heme oxygenase-1 expression in the uterus. Front. Endocrinol. 5:32 10.3389/fendo.2014.00032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Zenclussen M. L., Jensen F., Rebelo S., El-Mousleh T., Casalis P. A., Zenclussen A. C. (2012). Heme oxygenase-1 expression in the ovary dictates a proper oocyte ovulation, fertilization, and corpora lutea maintenance. Am. J. Reprod. Immunol. 67 376–382 10.1111/j.1600-0897.2011.01096.x [DOI] [PubMed] [Google Scholar]
  99. Zhang Y., Zhang L., Wu J., Di C., Xia Z. (2013). Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response. J. Biol. Chem. 288 34612–34626 10.1074/jbc.M113.494369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Zhao H., Azuma J., Kalish F., Wong R. J., Stevenson D. K. (2011). Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice. Biol. Reprod. 85 1005–1012 10.1095/biolreprod.111.093039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Zhao H., Wong R. J., Doyle T. C., Nayak N., Vreman H. J., Contag C. H., et al. (2008). Regulation of maternal and fetal hemodynamics by heme oxygenase in mice. Biol. Reprod. 78 744–751 10.1095/biolreprod.107.064899 [DOI] [PubMed] [Google Scholar]
  102. Zhao H., Wong R. J., Kalish F. S., Nayak N. R., Stevenson D. K. (2009). Effect of heme oxygenase-1 deficiency on placental development. Placenta 30 861–868 10.1016/j.placenta.2009.07.012 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES